@micoljb.bsky.social
Clonal Hematopoiesis, Therapy-related AML/MDS
Reposted
Excited to announce a new paper out today in @cp-cell.bsky.social discovering RNA mis-splicing derived neoantigens & their cognate T cell receptors (TCRs) as well as characterization of endogenous neoantigen T cells in leukemia patients.
authors.elsevier.com/sd/article/S...
authors.elsevier.com/sd/article/S...
ScienceDirect.com | Science, health and medical journals, full text articles and books.
authors.elsevier.com
April 23, 2025 at 8:30 PM
Excited to announce a new paper out today in @cp-cell.bsky.social discovering RNA mis-splicing derived neoantigens & their cognate T cell receptors (TCRs) as well as characterization of endogenous neoantigen T cells in leukemia patients.
authors.elsevier.com/sd/article/S...
authors.elsevier.com/sd/article/S...
Reposted
The full manuscript describing outcomes of 7 days Aza + 7 days Ven in newly diagnosed AML is out!
-72% composite CR rate
-mOS 11.2 months
www.nature.com/articles/s41...
-72% composite CR rate
-mOS 11.2 months
www.nature.com/articles/s41...
April 22, 2025 at 2:06 AM
The full manuscript describing outcomes of 7 days Aza + 7 days Ven in newly diagnosed AML is out!
-72% composite CR rate
-mOS 11.2 months
www.nature.com/articles/s41...
-72% composite CR rate
-mOS 11.2 months
www.nature.com/articles/s41...
Reposted
New paper from my lab! Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis: rdcu.be/eh1Nb Complementary to new work from Steven Chan & @georgevassiliou.bsky.social as described by @goodell-lab.bsky.social: www.nature.com/articles/d41...
Age-related blood condition counteracted with a common diabetes drug
Metformin could reduce people’s risk of certain age-associated blood cancers, but more work is needed to identify who is likely to benefit.
www.nature.com
April 16, 2025 at 9:02 PM
New paper from my lab! Elevated mitochondrial membrane potential is a therapeutic vulnerability in Dnmt3a-mutant clonal hematopoiesis: rdcu.be/eh1Nb Complementary to new work from Steven Chan & @georgevassiliou.bsky.social as described by @goodell-lab.bsky.social: www.nature.com/articles/d41...
Reposted
📢 ASH stands up for science! 🩸🧪🔬
Today, ASH joined fellow advocates at the @standupforscience.bsky.social rally to support continued investment in scientific research and innovation.
Let’s protect the future of #medicine, #research, and #patientcare together! 🙌💉
#Hematology #Hemesky #Medsky
Today, ASH joined fellow advocates at the @standupforscience.bsky.social rally to support continued investment in scientific research and innovation.
Let’s protect the future of #medicine, #research, and #patientcare together! 🙌💉
#Hematology #Hemesky #Medsky
March 7, 2025 at 6:03 PM
📢 ASH stands up for science! 🩸🧪🔬
Today, ASH joined fellow advocates at the @standupforscience.bsky.social rally to support continued investment in scientific research and innovation.
Let’s protect the future of #medicine, #research, and #patientcare together! 🙌💉
#Hematology #Hemesky #Medsky
Today, ASH joined fellow advocates at the @standupforscience.bsky.social rally to support continued investment in scientific research and innovation.
Let’s protect the future of #medicine, #research, and #patientcare together! 🙌💉
#Hematology #Hemesky #Medsky
Reposted
Stand-up for science : soutien à la communauté scientifique et universitaire qui se mobilise à Nancy comme ailleurs alors que la liberté académique, la recherche, la science font l'objet d'une attaque sans précédent par Donald Trump et ses alliés.
March 7, 2025 at 5:03 PM
Stand-up for science : soutien à la communauté scientifique et universitaire qui se mobilise à Nancy comme ailleurs alors que la liberté académique, la recherche, la science font l'objet d'une attaque sans précédent par Donald Trump et ses alliés.
Reposted
Great presentation by @ZhuoerXie showing similar characteristics of #CCUSsm and #MDSsm patients @ash-hematology.bsky.social #ASH24! Proud to be a part of this. @SylvesterCancer @UMiamiHealth @MoffittNews @nih_nhlbi
December 8, 2024 at 1:20 AM
Great presentation by @ZhuoerXie showing similar characteristics of #CCUSsm and #MDSsm patients @ash-hematology.bsky.social #ASH24! Proud to be a part of this. @SylvesterCancer @UMiamiHealth @MoffittNews @nih_nhlbi